Viewing all links from the source for category: Pharma/Biotech

15/09/2026

Radiopharm Theranostics Selected for Late-Breaking Oral Presentation of Positive Data from Interim Analysis of U.S. Phase 2b Imaging Trial of RAD101 at 2026 Society of Neuro-Oncology Annual Meeting

14/09/2026

Noxopharm: SOF-SKN™ to progress to extension study in CLE patients

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

11/09/2026

PYC Therapeutics: POLYCYSTIC KIDNEY DISEASE – FIRST PATIENT DOSED IN OPEN LABEL EXTENSION STUDY

10/09/2026

Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

Radiopharm Theranostics Announces Positive Data from the Phase 1 Imaging Trial of RAD301 in Patients with Pancreatic Ductal Adenocarcinoma

09/09/2026

CLINUVEL develops proprietary ZEROKIN™ device

02/09/2026

AdAlta’s partner to provide BZDS1901 CAR-T therapy to advanced mesothelioma patients under a special access scheme in China

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy

Kazia Therapeutics Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer

01/09/2026

Percheron: $2.3 MILLION INSTITUTIONAL PLACEMENT TO FULLY FUND NEW CLINICAL TRIAL IN AML

Orthocell: Results for the Full Year Ended 30 June 2026

Kazia Therapeutics Limited Announces Oversubscribed Closing of Up to $120 Million Public Offering

31/08/2026

PBS: Agenda for the September 2026 PBAC Meeting

28/08/2026

LTR Pharma: Appendix 4E and Annual Report to Shareholders

Patrys: HUMAN RESEARCH ETHICS COMMITTEE APPROVAL SECURED FOR PHASE 1A CLINICAL TRIAL

27/08/2026

Lumos: FY26 Full Year Results Announcement

Wesfarmers full results

Mayne Pharma: 2026 Full Year Results Media Release

Mayne Pharma: 2026 Appendix 4E and Annual Report

26/08/2026

Noxopharm: New preclinical data supports Noxopharm’s immuno-oncology approach

Radiopharm Theranostics Doses First Patient in Second Cohort of Phase 1/2a Clinical Trial of BetaBart (RV-01) in B7-H3 Expressing Solid Tumors

Starpharma: 2026 Annual Report

Funding boost to strengthen Australia’s drug discovery pipeline – WEHI

Radiopharm Theranostics Doses First Patientin Second Cohort of Phase 1/2a Clinical Trial of BetaBart(RV-01)in B7-H3 Expressing Solid Tumors

21/08/2026

Noxopharm: CEO reflections on global mRNA cancer vaccine news

Pro Medicus signs 7-year, A$25M contract with Valley Health

Nyrada: Xolatryp® Demonstrates Significant and Sustained Cardioprotection in Preclinical Doxorubicin Study

20/08/2026

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

Sonic Healthcare: Preliminary Final Report FY2026

Radiopharm Theranostics Receives Positive Recommendation from Data Safety and Monitoring Committee to Advance to Cohort 4 in 177Lu-RAD202 Phase 1 HEAT Clinical Trial

19/08/2026

REDENTIALED INTERNATIONAL BIOTECH LEADER JOINS INVION’S BOARD

Hansen Technologies: Stuart MacDonald appointedChief Executive Officer; Andrew Hansen to become Executive Chair; David Trude to retire as Chair

Lilly calls on online platforms, payment companies and regulators to shut down the illegal retatrutide black market

18/08/2026

Pro Medicus: FY26 Full Year Results

Cochlear: FY26 result met revised guidance with continued strategic progress to support growth

CSL to launch clinical trials to evaluate enhanced plasma manufacturing

CSL: FY26 a reset year; positioned to return to sustainable growth

14/08/2026

PRF’s $1.5M boost to fast-track Parkinson’s research at UOW

13/08/2026

Paradigm Biopharma: Phase 3 OA Trial Continues Unchanged Following Formal DSMB 80% Safety Review, September Interim Analysis on Track

12/08/2026

Alterity Therapeutics Announces Granting of New US Composition of Matter Patent for ATH434

Pro Medicus: PME signs 7-year, A$23M contract with St. Luke’s Health System

11/08/2026

SPONTAN®147-patient real-world study: 93% response in convenience-seeking men

Starpharma: ASX Announcement Successful Completion of $32 million Entitlement Offer

07/08/2026

Resmed Announces Results for the Fourth Quarter of FY2026

05/08/2026

BlinkLab (ASX:BB1) Commences Pivotal FDA Study for Smartphone AI Autism Diagnostic

04/08/2026

Zuellig Pharma Acquires Cialis (Tadalafil) from Lilly in Singapore

New issue of Australian Prescriber

31/07/2026

Radiopharm Theraneustics: Quarterly Activities/Appendix 4C Cash Flow Report